-transparent.png){kind=logo}
N-Nitroso-2,6-demethylmorpholine (NDMM) administered intraperitoneally to Syrian hamsters was metabolized to N-nitroso-bis(2-hydroxypropy)(2-oxopropyl)amine(HPOP) and N-nitroso-bis(2-hydroxpropyl)amine (BHP) which were identified in blood and urine. The potent pancreatic carcinogen N-nitroso-bis(2-oxoproply)amine was previously shown to form the same metabolites. Preliminary results indicate that NDMM also induces pancreatic and other tumors in Syrian hamsters, similar to those found following BHP treatment.
Related Publications
GingellR, and
L Wallcave, and
D Nagel, and
R Kupper, and
P Pour
November 1976,
Journal of the National Cancer Institute,
GingellR, and
L Wallcave, and
D Nagel, and
R Kupper, and
P Pour
April 1989,
Carcinogenesis,
GingellR, and
L Wallcave, and
D Nagel, and
R Kupper, and
P Pour
March 1984,
Journal of the National Cancer Institute,
GingellR, and
L Wallcave, and
D Nagel, and
R Kupper, and
P Pour
January 1981,
Cancer letters,
GingellR, and
L Wallcave, and
D Nagel, and
R Kupper, and
P Pour
April 1981,
Cancer letters,
GingellR, and
L Wallcave, and
D Nagel, and
R Kupper, and
P Pour
May 1987,
Journal of the National Cancer Institute,
GingellR, and
L Wallcave, and
D Nagel, and
R Kupper, and
P Pour
November 1983,
Toxicological European research. Recherche europeenne en toxicologie,
GingellR, and
L Wallcave, and
D Nagel, and
R Kupper, and
P Pour
April 1978,
Journal of the National Cancer Institute,
GingellR, and
L Wallcave, and
D Nagel, and
R Kupper, and
P Pour
August 1980,
Cancer letters,
GingellR, and
L Wallcave, and
D Nagel, and
R Kupper, and
P Pour
September 1987,
Cancer research,
